Indefinite Delivery Contract SPE2DU25D7088

This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion. It was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), the U.S. Coast Guard, and the U.S. Naval Fleet. The contract covers a comprehensive range of pharmaceutical products, including brand-name, generic, and specialty medications, as well as related medical supplies, across multiple therapeutic areas. The award is for separate regional line items, with the intent to have at least three different contractors to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The procurement was conducted as an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation method.

The original solicitation for this IDC was published by the DLA Troop Support Medical Supply Chain, with the intent to establish Prime Vendor Contracts to provide worldwide pharmaceutical support. The contracts will cover normal day-to-day operations, as well as planned and unplanned contingency, Prime Vendor Readiness (PVR), and War Readiness Materiel (WRM) support to both Continental United States (CONUS) and Outside the Continental United States (OCONUS) locations. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support these requirements.